(no title)
glp1guide | 6 months ago
https://trials.lilly.com/en-US/trial/580035
As one might imagine though, capitalism found a way. A LOT of compounding pharmacies are now very good at manufacturing GLP1s (not necessarily the case that the knowledge transfers, but I imagine networks/knowledge sharing groups do), so gray market has sprung up to supply adventurous people with Retatrutide.
ifwinterco|6 months ago
It started in the 90s with synthetic GH and since then the number of research peptides has exploded, all of which are readily available on the grey market.
So all the infrastructure for producing and distributing peptides was already there before GLP-1s were a thing, which probably explains why it didn't take long
globular-toast|6 months ago
I looked up which drugs are scheduled in the UK and found the list is about 100x longer than I thought it was and in fact the government don't even publish a definitive and exhaustive list of all substances.
ifwinterco|6 months ago
However, specific classes of drugs (synthetic cannabinoids and substituted phenylethylamines etc.) are banned in their entirety by designer drug legislation. This is to stop people producing stuff like mephedrone etc., because there's an almost endless potential for minor chemical substitutions while still retaining the effects.
AFAIK peptides are not covered by any of that legislation, so they are a grey area, hence why they get sold as "research chemicals" "not for human use" etc. Separately it's probably illegal to produce patented drugs like semaglutide through non-official channels, but that would be a civil/commercial matter, not a drugs offence per se
glp1guide|6 months ago